Does UPADACITINIB Cause Coronary artery bypass? 24 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Coronary artery bypass have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
24
Reports of Coronary artery bypass with UPADACITINIB
0.0%
of all UPADACITINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Coronary artery bypass From UPADACITINIB?
Of the 24 reports, 10 (41.7%) required hospitalization.
Is Coronary artery bypass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Coronary artery bypass?
ROSIGLITAZONE (1,181)
METFORMIN\ROSIGLITAZONE (181)
ADALIMUMAB (162)
EVOLOCUMAB (147)
AVANDIA (111)
RANOLAZINE (100)
RISANKIZUMAB-RZAA (93)
ETANERCEPT (76)
FLUTICASONE\SALMETEROL (75)
ASPIRIN (64)
Which UPADACITINIB Alternatives Have Lower Coronary artery bypass Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL